| Literature DB >> 31159752 |
Sjaan R Gomersall1, Tina L Skinner2, Elisabeth Winkler3, Genevieve N Healy3,4,5, Elizabeth Eakin3, Brianna Fjeldsoe3.
Abstract
BACKGROUND: Exercise interventions are typically delivered to people with cancer and survivors via supervised clinical rehabilitation. However, motivating and maintaining activity changes outside of the clinic setting remains challenging. This study investigated the feasibility, acceptability and efficacy of an individually-tailored, text message-enhanced intervention that focused on increasing whole-of-day activity both during and beyond a 4-week, supervised clinical exercise rehabilitation program for people with cancer and survivors.Entities:
Keywords: Cancer survivors; Exercise oncology; Physical activity; Randomised controlled trial; Sedentary behavior; Text messaging; Use of time
Mesh:
Year: 2019 PMID: 31159752 PMCID: PMC6546618 DOI: 10.1186/s12889-019-6767-4
Source DB: PubMed Journal: BMC Public Health ISSN: 1471-2458 Impact factor: 3.295
Type and frequency of text messages sent to the enhanced clinic group
| Text message types (targeted behavior) | Range of Frequency | Example Text |
|---|---|---|
| Educational tips (SB and MVPA) | Fixed: 2 per fortnight | Bob. Just standing up & stretching your legs can help your heart! Stand up today. Kylie |
| Real-time behavioral prompts (SB) | Variable: 2–10 per fortnight | Hi Bob. You’re probably watching TV now. Enjoy the downtime - but try to stand up & move in every ad break. Kylie |
| Real-time behavioral prompts (MVPA) | Variable: 1–4 per fortnight | Bob you wanted to walk early in the morning. Put your shoes out beside your bed now as a reminder. Kylie |
| Goal checks (MVPA) | Fixed: 1 per fortnight | Hi Bob. Did you reach your goal to walk 4 x 40mins this week? Text me back yes or no. Kylie |
| Goal check replies (MVPA) | Dependent on participant reply | We all lose motivation at times Bob. I know you can do it this week. Focus on your desire to be healthy - I am here to help you! Kylie |
SB sedentary behavior, MVPA moderate-to-vigorous physical activity
Fig. 1Participant flow diagram
Participant baseline characteristics
| Standard clinic ( | Text message-enhanced clinic (n = 18) | Overall ( | |
|---|---|---|---|
| Age (years) | 61.3 ± 9.1 | 68.3 ± 9.1 | 64.8 ± 9.6 |
| Body mass index (kg/m2) | 26.1 ± 4.2 | 26.5 ± 3.9 | 26.3 ± 4.0 |
| Gender (male) | 11 (61%) | 12 (67%) | 23 (64%) |
| Primary cancer | |||
| Colorectal | 12 (67%) | 13 (72%) | 25 (69%) |
| Prostate | 5 (28%) | 5 (28%) | 10 (28%) |
| Breast | 1 (6%) | 0 (0%) | 1 (3%) |
| Number of medications | |||
| None | 4 (22%) | 4 (22%) | 8 (22%) |
| 1 | 3 (17%) | 2 (11%) | 5 (14%) |
| ≥ 2 | 11 (61%) | 12 (67%) | 23 (64%) |
| Post-diagnosis (months) | 54.5 (38.0, 72.0) | 60.0 (47.0, 71.0) | 57.5 (43.5, 71.5) |
| Post treatment (months) | 38.5 (25.0, 66.0) | 51.0 (10.0, 61.0) | 46.0 (24.5, 61.0) |
| Activity (activPAL micro)a | |||
| Wear time (h) | 15.7 ± 0.7 | 15.9 ± 0.9 | 15.8 ± 0.8 |
| Sitting (h/16 h) | 9.4 ± 2.1 | 9.5 ± 1.8 | 9.4 ± 1.9 |
| Prolonged sitting (h/16 h) | 4.6 ± 2.2 | 4.7 ± 1.8 | 4.7 ± 2.0 |
| Standing (h/16 h) | 4.3 ± 1.5 | 4.3 ± 1.3 | 4.3 ± 1.4 |
| Stepping (h/16 h) | 2.4 ± 0.8 | 2.1 ± 0.7 | 2.3 ± 0.8 |
| Light stepping (min/16 h) | 95.3 ± 26.3 | 98.2 ± 22.8 | 96.7 ± 24.3 |
| MVPA (min/16 h) | 43.7 ± 28.8 | 31.1 ± 19.4 | 37.4 ± 25 |
MVPA moderate-to-vigorous physical activity. Table presents n (%), mean ± standard deviation or median (25th, 75th percentile) as appropriate
aAverage daily activity monitored on valid days (≥10 h wear, ≥500 strides, < 95% of time in any one activity), excluding non-wear and sleep
Satisfaction and usefulness of the enhanced clinic intervention (n = 17)
| Tailoring Sessions | Text Messages | |
|---|---|---|
| Satisfaction score (1–5), | 4.5 ± 0.6 | 4.1 ± 1.1 |
| Extremely satisfied, | 12 (71%) | 9 (53%) |
| Extremely useful for meeting physical activity goal, n(%) | 10 (59%) | 8 (47%) |
| Extremely useful for meeting sitting goal, n(%) | 8 (47%) | 8 (47%) |
| Read the text messages, n(%)a | – | 16 (100%) |
| Ease of understanding text messages a | ||
| Difficult/ very difficult | – | 0 (0%) |
| Easy | – | 2 (12%) |
| Very easy | – | 14 (88%) |
a excludes n = 1 participant with missing data
Changes in out-of-clinic activity (activPAL; min/16 h awake) in the standard clinic (C) and text message-enhanced clinic (EC)
| Week 4 (clinic cessation) | Week 12 (text cessation) | Week 12-Week 4 | |||||||
|---|---|---|---|---|---|---|---|---|---|
| n | M (95%CI) | p | n | M (95%CI) | p | M (95%CI) | p | ||
| Sitting (min/16 h awake) | C | 18 | 1.7 (−18.4, 21.8) | 0.869 | 15 | −0.5 (−30.2, 29.3) | 0.975 | −2.2 (−29.9, 25.6) | 0.878 |
| EC | 18 | −14.7 (−34.8, 5.3) | 0.151 | 17 |
|
|
|
| |
| EC-C | −16.4 (− 46.2, 13.4) | 0.281 |
|
|
|
| |||
| Prolonged sitting in ≥20 min bouts (min/16 h awake) | C | 18 | −8.2 (− 29.7, 13.2) | 0.452 | 15 | −8.3 (− 36.7, 20.2) | 0.569 | 0.0 (− 24.8, 24.7) | 0.998 |
| EC | 18 | −16.3 (−37.7, 5.2) | 0.137 | 17 |
|
|
|
| |
| EC-C | −8.0 (−39.9, 23.8) | 0.622 | −32.4 (−73.0, 8.3) | 0.119 | −24.4 (−58.4, 9.6) | 0.160 | |||
| Usual sitting bout duration (min) | C | 18 | −1.6 (−3.7, 0.5) | 0.143 | 15 | −0.1 (−2.6, 2.3) | 0.910 | 1.4 (−1.0, 3.9) | 0.247 |
| EC | 18 | −0.7 (−2.8, 1.4) | 0.526 | 17 |
|
|
|
| |
| EC-C | 0.9 (−2.2, 4.0) | 0.573 | −2.6 (−6.2, 0.9) | 0.143 |
|
| |||
| Standing (min/16 h awake) | C | 18 | −4.4 (−18.4, 9.5) | 0.535 | 15 | 2.2 (−30.8, 35.3) | 0.894 | 6.7 (−26.4, 39.7) | 0.693 |
| EC | 18 | 10.4 (−3.5, 24.4) | 0.143 | 17 |
|
|
|
| |
| EC-C | 14.8 (−6.1, 35.8) | 0.164 |
|
| 27.2 (−18.1, 72.6) | 0.239 | |||
| Stepping (min/16 h awake) | C | 18 | 3.7 (−6.8, 14.3) | 0.489 | 15 | −0.5 (−14.1, 13.0) | 0.940 | −4.2 (−17.8, 9.3) | 0.538 |
| EC | 18 | 3.5 (−6.9, 14.0) | 0.510 | 17 | 2.5 (−10.3, 15.4) | 0.698 | −1.0 (− 13.8, 11.8) | 0.881 | |
| EC-C | −0.2 (−15.7, 15.3) | 0.979 | 3.1 (−16.2, 22.3) | 0.756 | 3.3 (−15.3, 21.9) | 0.731 | |||
| Light stepping (min/16 h awake) | C | 18 | 1.0 (−0.7, 2.7) | 0.247 | 15 | 0.8 (−4.0, 5.6) | 0.749 | −0.2 (− 4.6, 4.2) | 0.916 |
| EC | 18 | 1.1 (−0.6, 2.9) | 0.191 | 17 |
|
|
|
| |
| EC-C | 0.1 (−2.4, 2.7) | 0.921 |
|
|
|
| |||
| Moderate-vigorous stepping (min/16 h awake) | C | 18 | 6.2 (−1.9, 14.3) | 0.131 | 15 | −0.4 (−7.3, 6.4) | 0.906 | −6.6 (− 14.7, 1.4) | 0.105 |
| EC | 18 | 1.6 (− 6.3, 9.6) | 0.685 | 17 | −3.1 (−9.7, 3.4) | 0.345 | −4.8 (−12.5, 2.9) | 0.222 | |
| EC-C | −4.6 (−16.4, 7.2) | 0.447 | −2.7 (−12.7, 7.3) | 0.593 | 1.9 (− 9.2, 13.0) | 0.743 | |||
Table presents mean change over time or mean difference between groups (M) with 95% Confidence Interval (CI) as estimated by mixed models adjusting for baseline values of the outcome, age (years), gender (male/female), time since diagnosis (months) and number of medications currently taken (0/1/≥2). Bold text indicates changes that were significant at p < 0.05
Changes in out-of-clinic time use by intensity (MARCA; min/day) in the standard clinic (C) and text message-enhanced clinic (EC)
| Week 4 (clinic cessation) | Week 12 (text cessation) | Week 12-Week 4 | |||||||
|---|---|---|---|---|---|---|---|---|---|
| n | M (95%CI) | p | n | M (95%CI) | p | M (95%CI) | p | ||
| Sleep | C | 17 |
|
| 15 | 21.3 (−13.6, 56.2) | 0.232 |
|
|
| EC | 18 | 1.9 (−30.1, 33.8) | 0.909 | 15 |
|
|
|
| |
| EC-C |
|
| 14.7 (− 36.7, 66.1) | 0.575 |
|
| |||
| Sitting | C | 17 | −10.4 (−54.8, 34.1) | 0.648 | 15 | 14.4 (−37.7, 66.6) | 0.587 | 24.8 (−18.4, 68) | 0.260 |
| EC | 18 | −29.5 (−72.5, 13.5) | 0.178 | 15 |
|
| − 36.2 (− 79.2, 6.9) | 0.100 | |
| EC-C | −19.2 (−84.5, 46.2) | 0.566 |
|
|
|
| |||
| LPA | C | 17 | 2.1 (−31.9, 36.1) | 0.903 | 15 | 15.5 (−13.6, 44.6) | 0.297 | 13.4 (−23.8, 50.6) | 0.481 |
| EC | 18 | 13.6 (−19.1, 46.4) | 0.415 | 15 | 8.4 (−20.7, 37.6) | 0.570 | −5.2 (−41.8, 31.4) | 0.782 | |
| EC-C | 11.5 (−37.7, 60.7) | 0.647 | −7.1 (−50.5, 36.4) | 0.750 | −18.6 (−70.8, 33.6) | 0.486 | |||
| MPA | C | 17 |
|
| 15 |
|
| −15.7 (− 52.7, 21.3) | 0.405 |
| EC | 18 | −1.8 (− 35.6, 32.0) | 0.916 | 15 | −7.5 (− 35.0, 20.0) | 0.592 | − 5.7 (−42.1, 30.7) | 0.759 | |
| EC-C | 35.4 (−14.9, 85.7) | 0.168 |
|
| 10.0 (−41.8, 61.8) | 0.705 | |||
| VPA | C | 17 | 0.2 (−6.3, 6.6) | 0.956 | 15 | 5.2 (−12.0, 22.4) | 0.554 | 5.0 (−12.4, 22.4) | 0.573 |
| EC | 18 |
|
| 15 |
|
| 8.2 (−9.2, 25.6) | 0.354 | |
| EC-C |
|
| 14.4 (−10.1, 39.0) | 0.249 | 3.2 (−21.4, 27.8) | 0.798 | |||
| MVPA | C | 17 |
|
| 15 |
|
| − 10.0 (− 41.5, 21.5) | 0.534 |
| EC | 18 | 13.0 (−20.5, 46.6) | 0.446 | 15 | 17.1 (−11.7, 46.0) | 0.244 | 4.1 (−27.0, 35.2) | 0.797 | |
| EC-C |
|
|
|
| 14.1 (−30.1, 58.3) | 0.533 | |||
LPA light physical activity, MPA moderate physical activity, VPA vigorous physical activity, MVPA moderate-to-vigorous physical activity. Table presents mean change over time or mean difference between groups (M) with 95% Confidence Interval (CI) as estimated by mixed models adjusting for baseline values of the outcome, age (years), gender (male/female), time since diagnosis (months) and number of medications currently taken (0/1/≥2). Bold text indicates changes that were significant at p < 0.05
Changes in out-of-clinic time use by domains (MARCA; min/day) in the standard clinic (C) and the text message-enhanced clinic (EC)
| Week 4 (clinic cessation) | Week 12 (text cessation) | Week 12-Week 4 | |||||||
|---|---|---|---|---|---|---|---|---|---|
| n | M (95%CI) | P | n | M (95%CI) | P | M (95%CI) | p | ||
| Chores (min/day) | C | 17 | −19.2 (−51.9, 13.5) | 0.249 | 15 | −26.3 (−64.5, 11.9) | 0.177 | −7.1 (−47.7, 33.6) | 0.734 |
| EC | 18 | −21.5 (−53.0, 10.1) | 0.182 | 15 | −11.1 (−49.2, 27.0) | 0.568 | 10.4 (−29.9, 50.7) | 0.614 | |
| EC-C | −2.2 (−50.1, 45.7) | 0.928 | 15.2 (−41.0, 71.4) | 0.5962 | 17.4 (−39.8, 74.6) | 0.550 | |||
| Cultural | C | 17 | −2.0 (−11.6, 7.6) | 0.682 | 15 |
|
| − 2.7 (− 13.2, 7.8) | 0.612 |
| EC | 18 | −0.2 (−9.5, 9.1) | 0.964 | 15 |
|
| − 4.5 (− 14.7, 5.6) | 0.382 | |
| EC-C | 1.8 (−11.6, 15.2) | 0.794 | 0.0 (−2.8, 2.7) | 0.978 | −1.8 (− 16.4, 12.8) | 0.806 | |||
| Physical Activity | C | 17 | 8.1 (−0.1, 16.4) | 0.054 | 15 |
|
| 9.0 (−1.9, 19.9) | 0.107 |
| EC | 18 |
|
| 15 |
|
| 5.8 (−5.2, 16.7) | 0.301 | |
| EC-C | 0.9 (−11.3, 13.1) | 0.881 | −2.3 (−22.9, 18.3) | 0.828 | −3.2 (−18.6, 12.2) | 0.682 | |||
| Quiet time | C | 17 | 7.2 (−17.8, 32.3) | 0.571 | 15 | 28.0 (−4.5, 60.4) | 0.091 | 20.7 (−15.1, 56.5) | 0.256 |
| EC | 18 | −14.7 (−38.9, 9.5) | 0.233 | 15 |
|
| −20.6 (−56.1, 14.9) | 0.256 | |
| EC-C | −21.9 (−58.4, 14.6) | 0.239 |
|
| −41.3 (−91.8, 9.1) | 0.108 | |||
| Screen time | C | 17 | 15.1 (−32.0, 62.1) | 0.530 | 15 | 1.4 (−56.7, 59.5) | 0.962 | −13.7 (−61.5, 34.2) | 0.576 |
| EC | 18 | 13.3 (−32.0, 58.7) | 0.564 | 15 | −48.6 (−106, 8.8) | 0.097 | −1.7 (−70.8, 67.3) | 0.960 | |
| EC-C | −50.0 (− 134.8, 34.7) | 0.247 |
|
| − 48.3 (− 115.9, 19.3) | 0.161 | |||
| Self-care | C | 17 | −1.9 (− 18.3, 14.4) | 0.818 | 15 | 3.8 (−12.1, 19.7) | 0.638 | 5.7 (−12.6, 24.1) | 0.541 |
| EC | 18 | 1.7 (−14.2, 17.5) | 0.836 | 15 | 0.5 (−15.3, 16.4) | 0.949 | −1.1 (− 19.3, 17.0) | 0.901 | |
| EC-C | 3.6 (−20.2, 27.4) | 0.768 | −3.3 (− 26.9, 20.3) | 0.784 | −6.9 (− 32.7, 18.9) | 0.601 | |||
| Social | C | 17 |
|
| 15 | −22.3 (−62.2, 17.6) | 0.274 | 18.7 (−18.6, 56.0) | 0.326 |
| EC | 18 | −22.5 (−47.9, 2.8) | 0.081 | 15 | 0.2 (−39.5, 39.8) | 0.994 | 18.4 (−22.0, 58.8) | 0.371 | |
| EC-C | 22.4 (−36.5, 81.3) | 0.455 | 22.7 (−14.5, 59.9) | 0.232 | 4.0 (−48.7, 56.7) | 0.881 | |||
| Transport | C | 17 | 4.5 (−23.0, 32.1) | 0.747 | 15 | 1.2 (−24.4, 26.7) | 0.929 | −3.4 (−37.9, 31.1) | 0.848 |
| EC | 18 | −6.4 (−33.1, 20.2) | 0.636 | 15 | 11.8 (−13.8, 37.4) | 0.368 | 18.2 (−15.8, 52.2) | 0.294 | |
| EC-C | −11 (−50.6, 28.6) | 0.587 | 10.6 (−27.0, 48.2) | 0.581 | 21.6 (−26.9, 70.0) | 0.383 | |||
| Work & Study | C | 17 | −4.9 (−33.3, 23.6) | 0.738 | 15 | −3.0 (− 32.8, 26.8) | 0.846 | 1.9 (−23.5, 27.3) | 0.883 |
| EC | 18 | 26.9 (−0.7, 54.5) | 0.056 | 15 | 27.1 (−2.4, 56.5) | 0.072 | 0.2 (−25.1, 25.4) | 0.991 | |
| EC-C | 31.8 (−12.3, 75.8) | 0.158 | 30.0 (− 16.1, 76.1) | 0.202 | − 1.7 (−37.5, 34.0) | 0.924 | |||
Table presents mean change over time or mean difference between groups (M) with 95% Confidence Interval (CI) as estimated by mixed models adjusting for baseline values of the outcome, age (years), gender (male/female), time since diagnosis (months) and number of medications currently taken (0/1/≥2). Bold text indicates changes that were significant at p < 0.05
Fig. 2Baseline to 12-week follow-up changes in most frequently reported sedentary behavior and moderate-to-vigorous physical activity activities from the MARCA by duration (min/week) in the text message-enhanced clinic. Note: Activities indicated by an asterisk are activities that are reported for the first time at follow-up and those shaded in black are activities that map directly onto commonly chosen intervention targets. MARCA = Multimedia Activity Recall for Children and Adults